OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Review of the Pharmacokinetic Characteristics of Immune Checkpoint Inhibitors and Their Clinical Impact Factors
Jun-Chen Liu, Hong-Jing Yu
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 29-36
Open Access | Times Cited: 8
Jun-Chen Liu, Hong-Jing Yu
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 29-36
Open Access | Times Cited: 8
Showing 8 citing articles:
Efficacy of innovative systemic treatments in combination with radiotherapy for bone metastases: a GEMO (the European Study Group of Bone Metastases) state of the art
Anna Gueiderikh, Jean Faivre, Constance Golfier, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Anna Gueiderikh, Jean Faivre, Constance Golfier, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
De-Escalation Strategies With Immune Checkpoint Blockers in Non–Small Cell Lung Cancer: Do We Already Have Enough Evidence?
Jordi Remón, Martina Bortolot, Paolo Bironzo, et al.
Journal of Clinical Oncology (2025)
Closed Access
Jordi Remón, Martina Bortolot, Paolo Bironzo, et al.
Journal of Clinical Oncology (2025)
Closed Access
Are We Ready to Face Conversion to Liver Transplantation of Advanced Hepatocellular Carcinoma after Treatment with Immune Checkpoint Inhibitors?
Luca Marzi, Andrea Mega, C Turri, et al.
(2024)
Open Access | Times Cited: 1
Luca Marzi, Andrea Mega, C Turri, et al.
(2024)
Open Access | Times Cited: 1
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver
Luca Marzi, Andrea Mega, C Turri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11676-11676
Open Access | Times Cited: 1
Luca Marzi, Andrea Mega, C Turri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11676-11676
Open Access | Times Cited: 1
Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting
Stephanie Berg, Salvatore La Rosa, Tian Zhang, et al.
Urologic Oncology Seminars and Original Investigations (2024)
Open Access | Times Cited: 1
Stephanie Berg, Salvatore La Rosa, Tian Zhang, et al.
Urologic Oncology Seminars and Original Investigations (2024)
Open Access | Times Cited: 1
Liver Transplantation for Hepatocellular Carcinoma: An Expanding Cornerstone of Care in the Era of Immunotherapy
Christian Tibor Josef Magyar, Grainne M. O’Kane, Laia Aceituno, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 1
Christian Tibor Josef Magyar, Grainne M. O’Kane, Laia Aceituno, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 1
Role of immunotherapy in managing cancers prior to liver transplantation
Philip Bredin, Zita Galvin, Grainne M. O’Kane
Current Opinion in Organ Transplantation (2024)
Closed Access
Philip Bredin, Zita Galvin, Grainne M. O’Kane
Current Opinion in Organ Transplantation (2024)
Closed Access
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Nephrotoxicity: A Position Statement from the American Society of Onco-nephrology
Sandra M. Herrmann, Ala Abudayyeh, Shruti Gupta, et al.
Kidney International (2024)
Closed Access
Sandra M. Herrmann, Ala Abudayyeh, Shruti Gupta, et al.
Kidney International (2024)
Closed Access
